UBS AM’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.67M Sell
778,905
-24,724
-3% -$186K ﹤0.01% 1586
2025
Q4
$5.76M Buy
803,629
+6,595
+0.8% +$52.1K ﹤0.01% 1387
2025
Q3
$8.51M Sell
797,034
-396,895
-33% -$3.9M ﹤0.01% 1128
2025
Q2
$11.6M Buy
1,193,929
+150,938
+14% +$1.56M ﹤0.01% 1290
2025
Q1
$15.5M Buy
1,042,991
+26,640
+3% +$410K ﹤0.01% 1064
2024
Q4
$15.2M Buy
1,016,351
+179,962
+22% +$2.93M ﹤0.01% 1065
2024
Q3
$16M Buy
836,389
+4,029
+0.5% +$83.5K ﹤0.01% 1032
2024
Q2
$17.2M Buy
832,360
+372,789
+81% +$7.41M ﹤0.01% 920
2024
Q1
$8.64M Sell
459,571
-7,640
-2% -$131K ﹤0.01% 1053
2023
Q4
$6.74M Sell
467,211
-51,053
-10% -$694K ﹤0.01% 1134
2023
Q3
$9M Sell
518,264
-138,504
-21% -$2.89M ﹤0.01% 991
2023
Q2
$15.4M Hold
656,768
0.01% 826
2023
Q1
$15.4M Buy
656,768
+12,983
+2% +$349K 0.01% 826
2022
Q4
$18M Buy
643,785
+20,910
+3% +$535K 0.01% 783
2022
Q3
$14.6M Sell
622,875
-67,692
-10% -$2.04M 0.01% 846
2022
Q2
$23.3M Buy
690,567
+42,485
+7% +$1.49M 0.01% 700
2022
Q1
$22.6M Buy
648,082
+25,432
+4% +$870K 0.01% 818
2021
Q4
$19M Buy
622,650
+28,210
+5% +$919K 0.01% 909
2021
Q3
$19.5M Buy
594,440
+15,262
+3% +$488K 0.01% 876
2021
Q2
$17.5M Buy
+579,178
New +$19.1M 0.01% 923

Other funds holding OGN